13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
|
Name |
WKN |
Börse |
Kurs |
Datum/Zeit |
Diff. |
Diff. % |
Geld |
Brief |
Erster |
Schluss |
|
SANOFI SA INHABER EO 2 |
920657 |
Xetra |
87,320 |
29.05.24 16:49:37 |
-1,280 |
-1,44% |
87,420 |
87,470 |
88,450 |
88,600 |
|
REGENERON PHARMAC.DL-,001 |
881535 |
Frankfurt |
888,200 |
29.05.24 08:34:17 |
-13,000 |
-1,44% |
886,000 |
891,600 |
888,200 |
901,200 |